Pfizer 2011 Annual Review | Pfizer: the world's largest research-based pharmaceutical company
READ
THE CEO
LETTER

Leading Medicines

Pfizer's portfolio includes 12 products with individual revenues exceeding $1 billion in 2011. Many of our leading prescription medicines are top-sellers in their categories, and are among the most widely recognized and well-tested treatments in the world.

  1. Key Medicines
  2. New From our pipeline
close
image description play